|
|
Volumn 143, Issue 2, 2002, Pages 187-188
|
|
Publication policy, informed consent, and the randomized clinical trial.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBIN;
DRUG DERIVATIVE;
HIRUDIN DERIVATIVE;
HIRULOG;
PEPTIDE FRAGMENT;
RECOMBINANT PROTEIN;
ADJUVANT CHEMOTHERAPY;
ANTICOAGULANT THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DECISION MAKING;
EDITORIAL;
HUMAN;
INFORMED CONSENT;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICOAGULANTS;
ANTITHROMBINS;
CHEMOTHERAPY, ADJUVANT;
CORONARY DISEASE;
DECISION MAKING;
HIRUDIN THERAPY;
HIRUDINS;
HUMANS;
INFORMED CONSENT;
PEPTIDE FRAGMENTS;
PUBLICATIONS;
RANDOMIZED CONTROLLED TRIALS;
RECOMBINANT PROTEINS;
MLCS;
MLOWN;
|
|
EID: 0036479875
PISSN: None
EISSN: 10976744
Source Type: Journal
DOI: 10.1067/mhj.2002.120406 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
